White Papers

Find Out Why Privacy Analytics Is a Top 3 Data Masking Provider Worldwide

The right data masking technology is critical to safely unlocking the value of your organization’s sensitive data for uses beyond its original intended...

Developing a Data-Sharing Leadership Playbook

Which strategies do you use to bolster your organization’s data-sharing initiatives? Are they primarily defensive or offensive?

Data Sharing: Strategies for an Uncertain World

What challenges and opportunities do you face when attempting to leverage and share sensitive data to drive innovation and increase ROI?

Unlock the Five Safes and Maximize your Data

Get the most out of your data without compromising compliance and patient confidentiality...

De-Identification 101: How to Protect Private Health Information

The growth in the use of electronic medical records, electronic insurance claims processing and other hospital software systems...

Safe Harbor Versus The Statistical Method

To leverage protected health information (PHI) for secondary purposes, an understanding of the different de-identification mechanisms is required...

Perspectives on Health Data De-identification

Has your organization been considering de-identification? It’s not a simple undertaking to use Protected Health Information (PHI) for secondary purposes.

How Do You Make a De-identification Expert?

The HIPAA “expert determination” method for de-identifying health data offers the most promising way to minimize privacy risk while maximizing data utility.

Anonymization for Analytics

Data has become a precious, prized asset for healthcare organizations looking to control costs and improve patient care...

ROI on De-identification

The business of de-identifying this data and using it for secondary purposes is only in its infancy...

De-identification Protocols

Learn what steps need to be taken in order to protect private data while limiting risk of re-identification.

The Definitive Guide to De-identification

More and more organizations are leveraging their health data for secondary purposes. They know just locking away their data in silos will no longer suffice.

What’s the Risk – Sharing Data for Secondary Use

Privacy Officers know that sharing data for secondary use is inherently an exercise in risk management.

Will the 21st Century Cures Act Help or Hinder Secondary Use of Health Data?

The 21st Century Cures Act is proposed legislation that aims to accelerate the discovery, development and delivery of life-saving therapies for patients...

Strengthening Secondary Use

Data registries are an invaluable tool that require the secondary use of data for conducting evidence-based healthcare research.

Unlocking Big Data for Healthcare

There are powerful opportunities facing healthcare today. Big Data Analytics (BDA) is being leveraged by a broad spectrum of healthcare organizations to solve ongoing challenges...

Managing Privacy: The Imperative RWE Capability

As privacy compliance standards are changing frequently, healthcare organizations need to be confident in their privacy practices when leveraging PHI for secondary uses.

MIT CDOIQ Symposium 2019 Summary

Globally renowned data privacy expert Luk Arbuckle – co-author of Anonymizing Health Data (O’Reilly Media) – co-moderated this invite-only, half-day deep dive into the complex topic of bridging the ...

A Privacy Governance Framework to Support De-identification

While technology is an important enabler of data de-identification, technology is not the end of the story.

RWE and Risk: A Primer

Balancing the Demand for Deep Data with Patient Privacy. As pharma companies have become more sophisticated in their use of real-world evidence (RWE), ...

De-Identification of Unstructured Data

De-identifying Unstructured Data to Enable Health Analytics. According to one organization, 80 percent of medical record data will be unstructured within the next two years.

Achieving Clinical Trials Transparency

Recent policy changes by Europe’s regulatory authority for drugs and devices has rekindled the pharmaceutical industry’s focus on clinical trials transparency.

Specialty Pharmaceuticals and Patient Privacy

In the specialty pharmaceutical industry, patient privacy is crucial. Privacy can be a challenge for companies looking to gather and consolidate patient...

Filter by Data Type

Categories